Ignite Creation Date:
2024-05-06 @ 6:58 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05847088
Status:
COMPLETED
Last Update Posted:
2023-05-06
First Post:
2023-04-05
Brief Title:
Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema
Sponsor:
Dar El Oyoun Hospital
Organization:
Dar El Oyoun Hospital
Study Overview
Official Title:
Intravitreal Dexamethasone Implant for Refractory Diabetic Macular Edema Anatomical and Functional Outcomes of Treatment and Retreatment
Status:
COMPLETED
Status Verified Date:
2023-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
We have been using DEX for refractory DME for a long time since 2016 Thus we are sharing our results evaluating both anatomical and functional outcomes of DEX therapy for refractory DME
Detailed Description:
Our study aims at evaluating both anatomical and functional outcomes of DEX therapy for cases of refractory DME with both a single injection and or with retreatments
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None